Regeneron has received an US Food and Drug Administration (FDA) rejection for a new blood cancer therapy and expects separate regulatory delays for blockbuster ophthalmology drug Eylea HD due to ...

A 19-year-old Slovakian student won $100,000 for his idea to make the antiviral drug, galidesivir, out of corn waste.